Mandrup-Poulsen, T., Mølvig, J., Andersen, V., Bendtzen, K., Binder, C., Brøns, M.
, d'Amore, F. A., Dieperink, H., Erik, B., Frandsen, NE., Haase, H., Hey, H., Juul, J., Karstoft, E., Kemp, E., Laursen, HB., Mogensen, EF., Nerup, J., Pedersen, KE. ... Sagild, U. (1990).
Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study.
Ugeskrift for Læger,
152(27), 1963-9.
Olsson, L., Behnke, O., Pleibel, N.
, d'Amore, F. A., Werdelin, O., Fry, KE. & Kaplan, HS. (1984).
Establishment and characterization of a giant cell line from a patient with Hodgkin's disease.
Journal of the National Cancer Institute,
73, 809-30.
Muzzulini, C.
, d'Amore, F. A., Sobrero, A., Massa, G., Bogliolo, G. & Pannacciulli, I. (1984).
Leucovorin protection on pluripotent hemopoietic stem cells in mice treated with high-dose methotrexate. Tumori,
70, 223-26.
Sobrero, A., Muzzulini, C.
, d'Amore, F. A., Bogliolo, G., Massa, G., Ghio, R. & Pannacciulli, I. (1982).
Activity of 4'-epi-doxorubicin on normal hematopoietic precursor cells in mice.
Cancer Treatment Report,
66(12), 2061-70.
Massa, G., Bogliolo, G.
, d'Amore, F. A., Muzzulini, C., Ghio, R. & Pannacciulli, I. (1982).
Haemopoietic precursor cells in mice treated with 4-demethoxydaunorubicin and doxorubicin.
Journal of the National Cancer Institute,
68, 971-976.
Muzzulini, C.
, d'Amore, F. A., Sobrero, A., Massa, G., Bogliolo, G., Ghio, R. & Pannacciulli, I. (1981).
Evaluation of doxorubicin toxicity on normal haemopoietic stem cells.
Tumori,
67, 293-300.